Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Shire US Inc.
Current Parent Company: Takeda Pharmaceutical
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $14,750,000
Year: 2016
Date: December 2, 2016
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Violation Description: Shire agreed to pay over $14 million to settle litigation alleging it paid rival drugmakers to delay introducing generic alternatives to the attention-deficit drug Adderall.
Level of Government: federal
Action Type: private litigation
Court: Southern District of Florida
Civil or Criminal Case: civil
Case ID: 1:13cv21158
Case Name: Barba et al v. Shire US, Inc. et al
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: Japan
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.